Patents by Inventor Yosuke TERAO
Yosuke TERAO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11542301Abstract: The present application addresses the problem of providing an Fc-binding protein having an improved antibody separation ability. The present application also addresses the problem of providing a high-accuracy antibody separation method using an insoluble carrier having the protein immobilized thereon. The problems can be solved by: an Fc-binding protein in which at least an amino acid substitution at a specific position therein occurs and which has reduced affinity for an antibody; and an antibody separation method including allowing an equilibration buffer solution to pass through a column in which an insoluble carrier having the protein immobilized thereon is filled to equilibrate the column, adding a solution containing an antibody to cause the adsorption of the antibody onto the carrier, and eluting the antibody adsorbed on the carrier using an elution solution.Type: GrantFiled: February 7, 2018Date of Patent: January 3, 2023Assignee: TOSOH CORPORATIONInventors: Yosuke Terao, Yoshiharu Asaoka, Ryoko Otake, Satoshi Endo, Naoki Yamanaka, Yukie Yamamoto, Seigo Oe
-
Publication number: 20220290749Abstract: A vehicle drive device is provided that can suppress the increase in dimension in the radial direction while ensuring a sufficient speed reduction ratio. Two driving force sources are arranged on a first axis, two output members are arranged on a second axis, two counter gear mechanisms are arranged on a third axis. A planetary gear mechanism is configured to transmit rotation from the two counter gear mechanisms to the output members, and is disposed so as to overlap with both of the two counter gear mechanisms as seen in an axial direction along and axial direction.Type: ApplicationFiled: August 28, 2020Publication date: September 15, 2022Applicants: AISIN CORPORATION, MITSUBISHI JIDOSHA KOGYO KABUSHIKI KAISHAInventors: Toshihisa MIZUTANI, Kenta KATAOKA, Taiki OWARI, Hiroaki OSANAI, Daiki SUYAMA, Hiroshi KATO, Yuki YANAGIHARA, Naoki TAKAHASHI, Kiminobu TERAO, Takuya OGASAWARA, Yosuke MORIMOTO
-
Patent number: 11427828Abstract: The present invention addresses the problem of providing FcRn having improved stability with respect to heat and acids, a method for producing said FcRn, an antibody adsorbent in which said FcRn is used, and an antibody isolation method in which said adsorbent is used. The above problem is solved by substituting an amino acid residue at a specific position in an extracellular region of a human FcRn ? chain and/or a ?2 microglobulin region of a human FcRn ? chain by another specific amino acid.Type: GrantFiled: April 13, 2018Date of Patent: August 30, 2022Assignee: TOSOH CORPORATIONInventors: Yosuke Terao, Naoki Yamanaka, Natsuko Kizu, Satoshi Endo, Seigo Oe
-
Patent number: 11414475Abstract: The problem to be addressed by the present invention is to provide improved recombinant Fc?RIIb and Fc?RIIa that do not require refolding and exhibit high productivity and thermal stability, and to provide a method for producing the same. Said problem is solved by improved recombinant Fc?RIIb comprising at least the amino acid residues of the extracellular domain of human Fc?RIIb (No. 43 to No. 215 in UniProt No. P31994), wherein, in said amino acid residues, at least one amino acid substitution has occurred at a position corresponding to No. 82, 94, 98, 104, 105, or 139 in UniProt No. P31994. Said problem is also solved by improved recombinant Fc?RIIa comprising at least the amino acid residues of the extracellular domain of human Fc?RIIa (No. 34 to No. 206 in UniProt No. P12318-1), wherein, in said amino acid residues, at least one amino acid substitution has occurred at a position corresponding to No. 73, 85, 89, 95, 96, or 130 in UniProt No. P12318-1.Type: GrantFiled: September 21, 2017Date of Patent: August 16, 2022Assignees: TOSOH CORPORATION, SAGAMI CHEMICAL RESEARCH INSTITUTEInventors: Kouta Hatayama, Teruhiko Ide, Hiroyuki Ito, Yosuke Terao, Naoki Yamanaka, Satoshi Endo
-
Publication number: 20210277053Abstract: The invention aims to provide an immunoglobulin-binding protein having improved chemical stability, especially stability against alkali. The object can be achieved by improving stability against alkali by substituting an amino acid residue(s) at a particular position(s) in an immunoglobulin-binding domain such as domain C of protein A derived from a bacterium belonging to the genus Staphylococcus, to another/other particular amino acid residue(s).Type: ApplicationFiled: November 8, 2018Publication date: September 9, 2021Applicant: TOSOH CORPORATIONInventors: Naoki YAMANAKA, Yukie UCHIDA, Yosuke TERAO
-
Publication number: 20210261605Abstract: The present invention relates to an Fc-binding protein exhibiting improved alkaline resistance, a method for producing said protein, an antibody adsorbent obtained by immobilizing said protein on a carrier, and a method for separating an antibody using said adsorbent.Type: ApplicationFiled: October 26, 2018Publication date: August 26, 2021Applicant: TOSOH CORPORATIONInventors: Ryoko WATANABE, Satoshi ENDO, Yosuke TERAO, Seigo OE
-
Publication number: 20210116445Abstract: An object of the present invention is to provide a method for detecting the presence or absence of a disease, the risk of developing a disease, the degree of progression of a disease and/or the degree of progression of aging, in a subject. The present invention achieves the above described object by a method including the following steps (a) to (c): (a) adding a solution containing an antibody obtained from a subject to a column filled with an insoluble carrier on which an Fc-binding protein is immobilized, to allow the antibody to be adsorbed on the carrier; (b) eluting the antibody adsorbed on the carrier using an eluent, to obtain data of a separation pattern of the antibody; and (c) detecting the presence or absence of a disease, the risk of developing a disease, the degree of progression of a disease and/or the degree of progression of aging, in the subject, using the data as an indicator.Type: ApplicationFiled: June 18, 2019Publication date: April 22, 2021Applicant: TOSOH CORPORATIONInventors: Yosuke TERAO, Yasuyuki AKIYAMA, Satoshi ENDO, Ryoko WATANABE
-
Publication number: 20210002367Abstract: An Fc-binding protein having at least amino acid residues of the extracellular domain of the amino acid sequence of wildtype human Fc?RIIa (UniProt Accession Number: P12318) wherein the amino acid residues in the domain have an amino acid substitution or deletion at at least a specific position, a method for producing the protein, and an antibody adsorbent using the protein.Type: ApplicationFiled: February 21, 2019Publication date: January 7, 2021Applicant: TOSOH CORPORATIONInventors: Masumi TAKAYAMA, Yosuke TERAO
-
Patent number: 10815289Abstract: Provided are: an Fc-binding protein having improved stability, particularly to heat and acid; a method for producing the protein; an antibody adsorbent using the protein; and a method for separating the antibodies using the adsorbent. Specifically provided are: an Fc-binding protein having improved stability to heat and acid, achieved by substituting an amino-acid residue in a specific position in the extracellular region of human FcyRIIIa with another specific amino acid; a method for producing the protein; an antibody adsorbent using the protein; and a method for separating the antibodies using the adsorbent.Type: GrantFiled: June 24, 2015Date of Patent: October 27, 2020Assignee: TOSOH CORPORATIONInventors: Yoshiharu Asaoka, Toru Tanaka, Yosuke Terao, Naoki Yamanaka, Natsuko Kizu, Masaru Aoki, Teruhiko Ide
-
Publication number: 20200283779Abstract: The present invention addresses the problem of providing FcRn having improved stability with respect to heat and acids, a method for producing said FcRn, an antibody adsorbent in which said FcRn is used, and an antibody isolation method in which said adsorbent is used. The above problem is solved by substituting an amino acid residue at a specific position in an extracellular region of a human FcRn ? chain and/or a ?2 microglobulin region of a human FcRn ? chain by another specific amino acid.Type: ApplicationFiled: April 13, 2018Publication date: September 10, 2020Applicant: TOSOH CORPORATIONInventors: Yosuke TERAO, Naoki YAMANAKA, Natsuko KIZU, Satoshi ENDO, Seigo OE
-
Publication number: 20200223885Abstract: The present application addresses the problem of providing an Fc-binding protein having an improved antibody separation ability. The present application also addresses the problem of providing a high-accuracy antibody separation method using an insoluble carrier having the protein immobilized thereon. The problems can be solved by: an Fc-binding protein in which at least an amino acid substitution at a specific position therein occurs and which has reduced affinity for an antibody; and an antibody separation method including allowing an equilibration buffer solution to pass through a column in which an insoluble carrier having the protein immobilized thereon is filled to equilibrate the column, adding a solution containing an antibody to cause the adsorption of the antibody onto the carrier, and eluting the antibody adsorbed on the carrier using an elution solution.Type: ApplicationFiled: February 7, 2018Publication date: July 16, 2020Applicant: TOSOH CORPORATIONInventors: Yosuke TERAO, Yoshiharu ASAOKA, Ryoko OTAKE, Satoshi ENDO, Naoki YAMANAKA, Yukie YAMAMOTO, Seigo OE
-
Publication number: 20190233499Abstract: The problem to be addressed by the present invention is to provide improved recombinant Fc?RIIb and Fc?RIIa that do not require refolding and exhibit high productivity and thermal stability, and to provide a method for producing the same. Said problem is solved by improved recombinant Fc?RIIb comprising at least the amino acid residues of the extracellular domain of human Fc?RIIb (No. 43 to No. 215 in UniProt No. P31994), wherein, in said amino acid residues, at least one amino acid substitution has occurred at a position corresponding to No. 82, 94, 98, 104, 105, or 139 in UniProt No. P31994. Said problem is also solved by improved recombinant Fc?RIIa comprising at least the amino acid residues of the extracellular domain of human Fc?RIIa (No. 34 to No. 206 in UniProt No. P12318-1), wherein, in said amino acid residues, at least one amino acid substitution has occurred at a position corresponding to No. 73, 85, 89, 95, 96, or 130 in UniProt No. P12318-1.Type: ApplicationFiled: September 21, 2017Publication date: August 1, 2019Applicants: TOSOH CORPORATION, SAGAMI CHEMICAL RESEARCH INSTITUTEInventors: Kouta HATAYAMA, Teruhiko IDE, Hiroyuki ITO, Yosuke TERAO, Naoki YAMANAKA, Satoshi ENDO
-
Publication number: 20190211077Abstract: Provided are: an Fc-binding protein having improved stability, particularly to heat and acid; a method for producing the protein; an antibody adsorbent using the protein; and a method for separating the antibodies using the adsorbent. Specifically provided are: an Fc-binding protein having improved stability to heat and acid, achieved by substituting an amino-acid residue in a specific position in the extracellular region of human FcyRIIIa with another specific amino acid; a method for producing the protein; an antibody adsorbent using the protein; and a method for separating the antibodies using the adsorbent.Type: ApplicationFiled: June 24, 2015Publication date: July 11, 2019Applicant: TOSOH CORPORATIONInventors: Yoshiharu ASAOKA, Toru TANAKA, Yosuke TERAO, Naoki YAMANAKA, Natsuko KIZU, Masaru AOKI, Teruhiko IDE
-
Publication number: 20170218044Abstract: Provided are: an Fc-binding protein having improved stability, particularly to heat and acid; a method for producing the protein; an antibody adsorbent using the protein; and a method for separating the antibodies using the adsorbent. Specifically provided are: an Fc-binding protein having improved stability to heat and acid, achieved by substituting an amino-acid residue in a specific position in the extracellular region of human FcyRIIIa with another specific amino acid; a method for producing the protein; an antibody adsorbent using the protein; and a method for separating the antibodies using the adsorbent.Type: ApplicationFiled: June 24, 2015Publication date: August 3, 2017Applicant: TOSOH CORPORATIONInventors: Yoshiharu ASAOKA, Toru TANAKA, Yosuke TERAO, Naoki YAMANAKA, Natsuko KIZU, Masaru AOKI, Teruhiko IDE